暨南大学学报(自然科学与医学版)
暨南大學學報(自然科學與醫學版)
기남대학학보(자연과학여의학판)
JOURNAL OF JINAN UNIVERSITY(NATURAL SCIENCE & MEDICINE EDITION)
2013年
6期
621-625
,共5页
杨爱成%肖炜%刘雅诗%魏连波%梁子安%马春成
楊愛成%肖煒%劉雅詩%魏連波%樑子安%馬春成
양애성%초위%류아시%위련파%량자안%마춘성
肾康丸%2型糖尿病%糖尿病肾病%TRAIL系统
腎康汍%2型糖尿病%糖尿病腎病%TRAIL繫統
신강환%2형당뇨병%당뇨병신병%TRAIL계통
Shenkangwan%Type 2 diabetes%diabetic nephropathy%TRAIL system
目的:观察肾康丸治疗对2型糖尿病(T2DM)大鼠肾组织TRAIL系统表达的影响,探讨其肾脏保护作用机制。方法:建立T2DM大鼠模型。成模后将大鼠随机分为2组:模型对照组(DM)、肾康丸组(DS);另设正常对照组(C)。分组干预,全自动生化仪检测高密度脂蛋白胆固醇(FBG)、总胆固醇(TC)及空腹血糖(FBG)(HDL-C);ELISA法检测尿微量白蛋白α1-MG(Uα1-MG)、24 h尿微量白蛋白(24h UmAlb),Q-RT-PCR法检测TRAIL、DR4、DcR2mRNA在肾组织表达,HE染色法观察大鼠肾组织病理变化。结果:随着实验时间的延长,DM组FBG及TC升高,HDL-C降低,而DS组FBG及TC降低,HDL-C升高;与C组相比,第4周、第8周DM组大鼠Uα1-MG、24h Um-Alb均显著升高(P<0.01,P<0.01),肾组织DcR2 mRNA表达显著增强(P<0.01);而TRAIL、DR4 mRNA表达显著减弱(P<0.01),并且DM组大鼠出现了肾脏组织病理损害;DS 组各指标均呈相反改变,肾脏病理损害减轻。结论:肾康丸通过影响TRAIL系统的表达,对T2DM大鼠具有显著的肾保护作用。
目的:觀察腎康汍治療對2型糖尿病(T2DM)大鼠腎組織TRAIL繫統錶達的影響,探討其腎髒保護作用機製。方法:建立T2DM大鼠模型。成模後將大鼠隨機分為2組:模型對照組(DM)、腎康汍組(DS);另設正常對照組(C)。分組榦預,全自動生化儀檢測高密度脂蛋白膽固醇(FBG)、總膽固醇(TC)及空腹血糖(FBG)(HDL-C);ELISA法檢測尿微量白蛋白α1-MG(Uα1-MG)、24 h尿微量白蛋白(24h UmAlb),Q-RT-PCR法檢測TRAIL、DR4、DcR2mRNA在腎組織錶達,HE染色法觀察大鼠腎組織病理變化。結果:隨著實驗時間的延長,DM組FBG及TC升高,HDL-C降低,而DS組FBG及TC降低,HDL-C升高;與C組相比,第4週、第8週DM組大鼠Uα1-MG、24h Um-Alb均顯著升高(P<0.01,P<0.01),腎組織DcR2 mRNA錶達顯著增彊(P<0.01);而TRAIL、DR4 mRNA錶達顯著減弱(P<0.01),併且DM組大鼠齣現瞭腎髒組織病理損害;DS 組各指標均呈相反改變,腎髒病理損害減輕。結論:腎康汍通過影響TRAIL繫統的錶達,對T2DM大鼠具有顯著的腎保護作用。
목적:관찰신강환치료대2형당뇨병(T2DM)대서신조직TRAIL계통표체적영향,탐토기신장보호작용궤제。방법:건립T2DM대서모형。성모후장대서수궤분위2조:모형대조조(DM)、신강환조(DS);령설정상대조조(C)。분조간예,전자동생화의검측고밀도지단백담고순(FBG)、총담고순(TC)급공복혈당(FBG)(HDL-C);ELISA법검측뇨미량백단백α1-MG(Uα1-MG)、24 h뇨미량백단백(24h UmAlb),Q-RT-PCR법검측TRAIL、DR4、DcR2mRNA재신조직표체,HE염색법관찰대서신조직병리변화。결과:수착실험시간적연장,DM조FBG급TC승고,HDL-C강저,이DS조FBG급TC강저,HDL-C승고;여C조상비,제4주、제8주DM조대서Uα1-MG、24h Um-Alb균현저승고(P<0.01,P<0.01),신조직DcR2 mRNA표체현저증강(P<0.01);이TRAIL、DR4 mRNA표체현저감약(P<0.01),병차DM조대서출현료신장조직병리손해;DS 조각지표균정상반개변,신장병리손해감경。결론:신강환통과영향TRAIL계통적표체,대T2DM대서구유현저적신보호작용。
Aim:To explore the effect of Shenkangwan on the expression of tumor necrosis factor-relat-ed apoptosis-inducing ligand system(TRAIL)in the kidneys of type 2 diabetes rats.Methods:The rat models of type 2 diabetes were randomly divided into diabetic model group (DM)and Shenkangwan treat-ment group (DS),with the rats fed with normal chow as the control group (C).After treatment,The FBG,TC and HDL-C were detected by automatic biochemical analyzer.The levels of urine α1-MG (Uα1-MG)and 24 hour urine mAlb (24h UmAlb)were detected by ELISA,and the expressions of TRAIL,death receptor 4 (DR4 )and decoy receptor 2 (DcR2 )protein and mRNA in the kidney were measured by immune histochemistry and quantitative real-time PCR(Q-RT-PCR),Then we investigated their renal pathological change under optical microscope with the coloration method of Hematoxylin and E-osin(HE).Results:The levels of FBG and TC increased while HDL-C reduced in the DMgroup,these changes were all reversed after treatment with Shenkangwan.Compared with C group,the levels of Uα1-MG,24h UmAlb,and the renal expressions of DcR2 protein and mRNA increased significantly (P <0.01 );however,the expressions of TRAIL and DR4 protein and mRNA(P<0.01 )reduced significantly and came forth about the renal pathological lesion in the DM group.These changes were all reversed and the renal pathological lesion was mitigated after treatment with Shenkangwan.Conclusion:Shenkangwan have significant renal protection on T2DMrats,its mechanisms may be the effects on expression of TRAIL system.